Healthcare -
Biotechnology - NASDAQ - US
$ 1.135
-12 %
$ 4.72 M
Market Cap
-0.09
P/E
MBRX - LONG-TERM DEBT
Long-term Debt MBRX - Moleculin Biotech, Inc.
474 K
LAST VALUE
174.30%
2 YEAR CAGR
0.00%
5 YEAR CAGR
0.00%
10 YEAR CAGR